covid19 vaccineslee said mrna vaccine makers may be reluctant to share their technology but they can take advantage of south koreas raw material suppliers to address a global shortage of such ingredients as lipids nucleotides and capping reagentstheyre capable of manufacturing and developing such raw materials to help vaccine makers and the south korean government is committed to provide all necessary support including financial and administrative aidlee said the country also has a capacity for at least another 500 million doses of fillandfinish vaccines apart from the deal moderna announced with samsung biologics in maysouth korea has deals to buy 106 million doses of mrna vaccines from pfizer and moderna to cover full vaccination of its population of 52 million this year the government said last week it would purchase more mrna shots to use them as a booster shot next year